1400683-07-9

Upstream product

• 1400683-29-5 (R)-5-(5-amino-2-fluorophenyl)-6,6-difluoro-5-methyl-1,4-oxazepan-3-one 
• 1400683-30-8 (5R)-5-(5-(3-chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ylamino)-2-fluorophenyl)-6,6-difluoro-5-methyl-1,4-oxazepan-3-one 
• 1400683-01-3 (R)-5-[5-(benzhydrylidene-amino)-2-fluoro-phenyl]-6,6-difluoro-5-methyl-[1,4]oxazepan-3-one 
• 126215-93-8 3-chloro-6,7-dihydro-5H-1-pyrindine 
• 1357097-06-3 3-chloro-5H-cyclopentapyridin-7(6H)-one 
• 1357097-05-2 3-chloro-6,7-dihydro-5H-cyclopentapyridin-7-ol 
• 1357097-04-1 acetic acid 3-chloro-6,7-dihydro-5H-[1]pyrindin-7-yl ester 
• 1357097-03-0 3-chloro-6,7-dihydro-5H-cyclopentapyridine 1-oxide 

Relevant academic research and scientific papers

1,4-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS

The present invention relates to 1,4-Oxazepines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the pres

1,4-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS

The present invention relates to 1,4-Oxazepines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the pres